Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Physician-Initiated Randomised, Multiple-Dose, Single Period, Phase II Dose Ranging Study to Examine Transdermal Human Insulin In Adult Healthy Volunteer Patients

NCT04857320 is registered in ClinicalTrials.gov with Transdermal Delivery Solutions Corp as lead sponsor.

NCT NCT04857320
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04857320 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Physician-Initiated Randomised, Multiple-Dose, Single Period, Phase II Dose Ranging Study to Examine Transdermal Human Insulin In Adult Healthy Volunteer Patients
Lead sponsor
Transdermal Delivery Solutions Corp
Phase
Phase 1
Overall status
Completed
Start date
March 12, 2021
Completion date
November 15, 2021
Enrollment
7 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pharmacodynamic response to small doses of insulin